The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress
Open accessAbstract
Certain pleiotropic activities reported for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are related to reductions in cellular cholesterol biosynthesis and isoprenoid levels. In endothelial cells, these metabolic changes contribute to favorable effects on nitric oxide (NO) bioavailability. Given the essential role of NO in preserving vascular structure and function, this effect of statins is of considerable therapeutic importance. Statins have been demonstrated to restore endothelial NO production by several mechanisms, including upregulating endothelial NO synthase (eNOS) protein expression and blocking formation of reactive oxygen species. In this article, we will discuss additional ways in which statins restore endothelial NO production and improve endothelial function. (1) Statins modulate membrane microdomain formation, resulting in reduced expression of proteins that specifically inhibit eNOS activation. (2) Statins reduce sterol biosynthesis, thus interfering with the formation of pathologic microdomains, including cholesterol crystalline structures. This observation has important implications for plaque stabilization, as these microdomains contribute to cholesterol crystal formation and endothelial apoptosis. Finally, (3) statins improve endothelial function by interfering with oxidative stress pathways through both enzymatic and nonenzymatic mechanisms. The relationships between membrane microdomains, cholesterol biosynthesis, and endothelial function will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Statins and angiotensin type 1 receptor blockers have been shown to reduce oxidative stress and inflammation, improving endothelial function.”
In the citing paper
“Statins and angiotensin type 1 (AT-1) receptor blockers are widely used in preventing CVD and diabetic complications, and it has been suggested that many of their ancillary effects are due to strong intracellular antioxidant activity.”
In the citing paper
“Statins and AT-1 receptor inhibitors work as antioxidant in different ways.”
In the citing paper
“Statins and AT-1 receptor blockers protect endothelial function and reduce inflammation in diabetic and nondiabetic subjects, and these effects are convincingly mediated through their intracellular antioxidant activity.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Warren, Β. E. (1968) · Cited by 5,833
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts
Brown, D. A., & London, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000005200 · Cited by 2,344
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,885
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Dráb, M., Verkade, P., Elger, M., Kasper, M. E., Löhn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,555
Cholesterol and the cell membrane
Yèagle, P. L. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(85)90011-5 · Cited by 1,492
Research works printed but not linked: 18
- 10.1161/atvb.19.8.1891 · DOI
- 1991, FASEB J, 5, A531.
- 1992, Comments Mol Cell Biophys, 8, 53
- 10.1161/circ.101.11.1261 · DOI
- 1989, Am J Physiol, 257, H170
- 10.1161/res.69.1.2054935 · DOI
- 1995, J Membr Biol, 143, 51
- 10.1161/atvb.17.7.1337 · DOI
- 10.1161/circ.91.11.2844 · DOI
- 1989, Am J Pathol, 134, 705
- 10.1161/atvb.18.3.423 · DOI
- 10.1161/atvb.17.11.2975 · DOI
- 10.1161/circ.98.25.2822 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.97.12.1129 · DOI
- 10.1161/atvb.20.1.61 · DOI
- 10.1161/atvb.22.2.300 · DOI
Cited by
Sorted by citations
Oxidative stress and diabetic cardiovascular complications
Jay, D., Hitomi, H., & Griendling, K. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.018 · Cited by 464
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 409
Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., et al. (2006) · JAMA · doi:10.1001/jama.295.1.58 · Cited by 357
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
SenBanerjee, S., Mir, S. S., Lin, Z., Hamik, A., Atkins, G. B., Das, H., Banerjee, P., Kumar, A., & Jain, M. K. (2005) · Circulation · doi:10.1161/circulationaha.104.525774 · Cited by 348
Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K., & Giugliano, D. (2005) · Circulation · doi:10.1161/01.cir.0000165070.46111.9f · Cited by 298
Becker, S. A., & Palsson, B. Ø. (2005) · BMC Microbiology · doi:10.1186/1471-2180-5-8 · Cited by 255
Maki-Petaja, K. M., Booth, A. D., Hall, F. C., Wallace, S. M. L., Brown, J., McEniery, C. M., & Wilkinson, I. B. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.076 · Cited by 241
Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy
Dulak, J., & Józkowicz, A. (2005) · Current Cancer Drug Targets · doi:10.2174/156800905774932824 · Cited by 235
Usharani, P., Mateen, A., Naidu, M. U. R., Raju, Y. S. N., & Chandra, N. (2008) · Drugs in R&D · doi:10.2165/00126839-200809040-00004 · Cited by 200
Brocq, M. L. L., Leslie, S. J., Milliken, P. H., & Megson, I. L. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.2013 · Cited by 196
Pavlakou, P., Liakopoulos, V., Eleftheriadis, T., Mitsis, M., & Dounousi, E. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6193694 · Cited by 178
Overviews of Pathogen Emergence: Which Pathogens Emerge, When and Why?
Cleaveland, S., Haydon, D. T., & Taylor, L. H. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_5 · Cited by 161
Mason, R. P., Walter, M. F., Day, C. A., & Jacob, R. F. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.008 · Cited by 153
Self-citationStatins as antiinflammatory and immunomodulatory agents: A future in rheumatologic therapy?
Abeles, A. M., & Pillinger, M. H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21521 · Cited by 151
Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
Herman, A. G., & Moncada, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi333 · Cited by 156
Kotamraju, S., Willams, C. L., & Kalyanaraman, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0993 · Cited by 146
The Role of Oxidative Stress in the Metabolic Syndrome
Whaley‐Connell, A. T., McCullough, P. A., & Sowers, J. R. (2011) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0555 · Cited by 146
The role of mitochondria in statin‐induced myopathy
Apostolopoulou, M., Corsini, A., & Roden, M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12461 · Cited by 142
Reactive Oxygen and Nitrogen Species in Pathogenesis of Vascular Complications of Diabetes
Son, S. M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.190 · Cited by 125
Wei, Y.-M., Li, X., Xu, M., Abais, J. M., Chen, Y., Riebling, C. R., Boini, K. M., Li, P., & Zhang, Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350111 · Cited by 125
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins
Santilli, F., Bucciarelli, L. G., Noto, D., Cefalu, A. B., Davì, V., Ferrante, E., Pettinella, C., Averna, M. R., Ciabattoni, G., & Davı̀, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.06.017 · Cited by 124
Abela, G. S., & Aziz, K. S. (2006) · Scanning · doi:10.1002/sca.4950280101 · Cited by 123
Chapman, M. J., & Sposito, A. C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.004 · Cited by 123
Shah, S., Iqbal, M., Karam, J., Salifu, M., & McFarlane, S. I. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1629 · Cited by 115
Sphingosine-1-phosphate and modulation of vascular tone
Igarashi, J., & Michel, T. M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp064 · Cited by 119
Terasaka, N., Westerterp, M., Koetsveld, J., Fernández-Hernando, C., Yvan-Charvet, L., Wang, N., Sessa, W. C., & Tall, A. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213215 · Cited by 107
Potential Benefits and Risks Associated with the Use of Statins
Khatiwada, N., & Hong, Z. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020214 · Cited by 119
Statins for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis
Zhang, T., Shen, L., Hu, L., & He, B. (2011) · American Journal of Nephrology · doi:10.1159/000326269 · Cited by 98
Goicoechea, M., de Vinuesa, S. G., Lahera, V., Cachofeiro, V., Gómez-Campderá, F. J., Vega, A., Abad, S., & Luño, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080938 · Cited by 97
Role of EPA in Inflammation: Mechanisms, Effects, and Clinical Relevance
Crupi, R., & Cuzzocrea, S. (2022) · Biomolecules · doi:10.3390/biom12020242 · Cited by 97
Erdös, B., Snipes, J. A., Tulbert, C. D., Katakam, P. V. G., Miller, A. W., & Busija, D. W. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00804.2005 · Cited by 90
Hsu, C.-Y., Chen, Y.-T., Su, Y.-W., Chang, C.-C., Huang, P.-H., & Lin, S.-J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3717 · Cited by 89
Abela, G. S., & Aziz, K. S. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280906 · Cited by 89
Mason, R. P., Dawoud, H., Jacob, R. F., Sherratt, S. C. R., & Maliñski, T. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.118 · Cited by 87
Self-citationAntioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
Moon, G. J., Kim, S. J., Cho, Y. H., Ryoo, S., & Bang, O. Y. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.2.140 · Cited by 82
Grading and Interpretation of White Matter Hyperintensities Using Statistical Maps
Ryu, W., Woo, S., Schellingerhout, D., Chung, M. K., Kim, C. K., Jang, M. U., Park, K. J., Hong, K., Jeong, S., Na, J.-Y., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006662 · Cited by 82
Statins and autoimmunity: State-of-the-art
Dehnavi, S., Sohrabi, N., Sadeghi, M., Lansberg, P. J., Banach, M., Al‐Rasadi, K., Johnston, T. P., & Sahebkar, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107614 · Cited by 81
Statins in neurological disorders: An overview and update
Malfitano, A. M., Marasco, G., Proto, M., Laezza, C., Gazzerro, P., & Bifulco, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.007 · Cited by 83
Microvascular responsiveness in obesity: implications for therapeutic intervention
Bagi, Z. A., Fehér, A., & Cassuto, J. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01606.x · Cited by 69
Role of Nadph Oxidase in Atherosclerosis
Violi, F., Basili, S., Nigro, C., & Pignatelli, P. (2008) · Future Cardiology · doi:10.2217/14796678.5.1.83 · Cited by 73
Mason, R. P., Sherratt, S. C. R., & Jacob, R. F. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000379 · Cited by 72
Self-citationErythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm
Poisson, J., Tanguy, M., Davy, H., Camara, F., Mdawar, M.-B. E., Kheloufi, M., Dagher, T., Devue, C., Lasselin, J., Plessier, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124566 · Cited by 70
Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes
Son, S. M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.036 · Cited by 69
Chemoprevention of Hormone Receptor-Negative Breast Cancer: New Approaches Needed
Uray, I. P., & Brown, P. H. (2010) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-10858-7_13 · Cited by 68
Therapeutic neovascularization for coronary disease: current state and future prospects
Lassaletta, A. D., Chu, L. M., & Sellke, F. W. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0200-1 · Cited by 64
Lecarpentier, É., Morel, O., Fournier, T., Éléfant, É., Chavatte‐Palmer, P., & Tsatsaris, V. (2012) · Drugs · doi:10.2165/11632010-000000000-00000 · Cited by 66
Aspects of Nitric Oxide in Health and Disease: A Focus on Hypertension and Cardiovascular Disease
Giles, T. D. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.06023.x · Cited by 61
Lipid rafts: A signalling platform linking lipoprotein metabolism to atherogenesis
Lemaire‐Ewing, S., Lagrost, L., & Néel, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.016 · Cited by 58
Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs
Hoyos, P., Pace, V., & Alcántara, A. R. (2019) · Catalysts · doi:10.3390/catal9030260 · Cited by 61
Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption
Yi, J.-S., Choo, H. J., Cho, B.-R., Kim, H.-M., Kim, Y.-N., Ham, Y., & Ko, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.028 · Cited by 56
Molecular Basis of Differences Among Statins and a Comparison with Antioxidant Vitamins
Mason, R. P. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.09.018 · Cited by 56
Self-citationOngoing clinical trials of the pleiotropic effects of statins
Davignon, J., & Leiter, L. A. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.1.1.29.58937 · Cited by 51
Influenza Viruses in Animal Wildlife Populations
Webby, R. J., Webster, R. G., & Richt, J. A. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_4 · Cited by 55
Mayanagi, K., Katakam, P. V. G., Gáspár, T., Domoki, F., & Busija, D. W. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.81 · Cited by 53
IGARASHI, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.06.008 · Cited by 53
Tanaka, N., Abe-Dohmae, S., Iwamoto, N., Fitzgerald, M. L., & Yokoyama, S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.031 · Cited by 50
Kumar, A., Ghate, V. S., Kim, M., Zhou, W., Khoo, G. H., & Yuk, H. (2016) · Food Microbiology · doi:10.1016/j.fm.2016.10.032 · Cited by 50
Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice
Buus, N. H., Hansson, N. C., Rodríguez‐Rodríguez, R., Stankevıčıus, E., Andersen, M. R., & Simonsen, U. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.037 · Cited by 49
Gu, M., Mordwinkin, N. M., Kooreman, N. G., Lee, J., Wu, H., Hu, S., Churko, J. M., Diecke, S., Burridge, P. W., He, C., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu411 · Cited by 46
Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy
Tamargo, J. L., Caballero, R., Gómez, R. J., Núñez, L., Vaquero, L. M., & Delpón, E. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.12.002 · Cited by 46
Yoshida, S., Kamihata, H., Nakamura, S., Senoo, T., Manabe, K., Motohiro, M., Sugiura, T., & Iwasaka, T. (2009) · Journal of Cardiology · doi:10.1016/j.jjcc.2009.05.006 · Cited by 45
Cho, K.-J., Hill, M. M. C., Chigurupati, S., Du, G., Parton, R. G., & Hancock, J. F. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00989-10 · Cited by 44
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Davis, B. B., Zeki, A. A., Bratt, J. M., Wang, L., Filosto, S., Walby, W. F., Kenyon, N. J., Goldkorn, T., Schelegle, E. S., & Pinkerton, K. E. (2012) · European Respiratory Journal · doi:10.1183/09031936.00042512 · Cited by 44
Amelioration of cisplatin-induced nephrotoxicity by statins
Maheshwari, R. A., Sailor, G. U., Patel, L., & Balaraman, R. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.115016 · Cited by 44
Zhai, Y., Gao, X., Wu, Q., Peng, L., Lin, J., & Zuo, Z. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.006 · Cited by 43
Cardiovascular bioimaging of nitric oxide: Achievements, challenges, and the future
Vidanapathirana, A. K., Psaltis, P. J., Bursill, C. A., Abell, A. D., & Nicholls, S. J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21736 · Cited by 44
Piccirillo, F., Carpenito, M., Verolino, G., Chello, C., Nusca, A., Lusini, M., Spadaccio, C., Nappi, F., Sciascio, G. D., & Nenna, A. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111161 · Cited by 42
Konduracka, E., Galicka-Latała, D., Cieślik, G., Rostoff, P., Fedak, D., Sieradzki, J., Naskalski, J. W., & Piwowarska, W. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00798.x · Cited by 41
Boodhwani, M., Nakai, Y., Voisine, P., Feng, J., Li, J., Mieno, S., Ramlawi, B., Bianchi, C. F., Laham, R. J., & Sellke, F. W. (2006) · Circulation · doi:10.1161/circulationaha.105.000356 · Cited by 40
Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
Wei, Y.-M., Li, X., Xiong, J., Abais, J. M., Xia, M., Boini, K. M., Zhang, Y., & Li, P. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201442 · Cited by 39
Synergistic Effect of Amlodipine and Atorvastatin in Reversing LDL-Induced Endothelial Dysfunction
Mason, R. P., Kubant, R., Heeba, G. H., Jacob, R. F., Day, C. A., Self-Medlin, Y., Funovics, P. T., & Maliñski, T. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9491-1 · Cited by 38
Self-citationCholesterol in Brain Development and Perinatal Brain Injury: More than a Building Block
Lu, F., Ferriero, D. M., & Jiang, X. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666211111122311 · Cited by 39
John, M., Cockcroft, J., McKeever, T. M., Coward, W. R., Shale, D. J., Johnson, S. R., Thornton, J., Harrison, T. W., Knox, A. J., & Bolton, C. E. (2015) · International Journal of COPD · doi:10.2147/copd.s76061 · Cited by 37
Klein, L. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.039 · Cited by 38
Nitric Oxide Mechanisms in the Pathogenesis of Global Risk
Mason, R. P. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05838.x · Cited by 36
Self-citationFichtenbaum, C. J., Yeh, T., Evans, S. R., & Aberg, J. A. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.04.003 · Cited by 35
Statins reduce relapse rate in Takayasu arteritis
Kwon, O. C., Oh, J. S., Park, M., Hong, S., Lee, C., Yoo, B., & Kim, Y. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.046 · Cited by 33
Robinson, J. G. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.060 · Cited by 33
Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats
Chen, C.-H., Lee, R.-P., Wu, W.-T., Liao, K., Hsu, N., & Hsu, B. (2007) · Resuscitation · doi:10.1016/j.resuscitation.2006.12.002 · Cited by 33
Mood, G. R., Bavry, A. A., Roukoz, H., & Bhatt, D. L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.022 · Cited by 31
Fujii, T., Onimaru, M., Yonemitsu, Y., Kuwano, H., & Sueishi, K. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00149.2008 · Cited by 30
Rambaran, C., Jiang, B., Ritter, J. M., Shah, A. M., Kalra, L., & Chowienczyk, P. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03006.x · Cited by 30
Wang, X., Zhang, T., Hu, L., Sun, S., Zhang, W., Sun, Z., Shen, L., & He, B. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6282486 · Cited by 27
Chen, C., Chen, Y., Lin, M., Huang, Y., Chang, F., Duh, T., Wu, D., Wu, W.-C., Kao, Y.-C., & Yang, P.-H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140249 · Cited by 28
Simvastatin improves lysosome function via enhancing lysosome biogenesis in endothelial cells
Li, X. (2019) · Frontiers in bioscience · doi:10.2741/4807 · Cited by 25
Effects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL
Peters, N., Freilinger, T. M., Opherk, C., Pfefferkorn, T., & Dichgans, M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.04.015 · Cited by 27
Yoshimura, K., Nakano, H., Yokoyama, K., & Nakayama, M. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0354-y · Cited by 26
Zhang, B., Naik, J. S., Jernigan, N. L., Walker, B. R., & Resta, T. C. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00540.2017 · Cited by 24
A rationale for combination therapy in risk factor management: a mechanistic perspective
Mason, R. P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.021 · Cited by 24
Self-citationPotential therapeutic role of statins in neurological disorders
Bifulco, M., Malfitano, A. M., & Marasco, G. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.827 · Cited by 23
Pucci, A., Formato, L., Muscio, M., Brscic, E., Pizzimenti, S., Ferroni, F., Ribezzo, M., Toaldo, C., Pettazzoni, P., Ciamporcero, E. S., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.009 · Cited by 22
Geng, J., Zhao, Z., Kang, W., Wang, W., Zhang, Y., & Zhiming, G. E. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.08.004 · Cited by 22
Boodhwani, M., Mieno, S., Voisine, P., Feng, J., Sodha, N. R., Li, J., & Sellke, F. W. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.05.060 · Cited by 22
In vivo coronary plaque histology in patients with stable and acute coronary syndromes
Pucci, A., Sheiban, I., Formato, L., Celeste, A., Brscic, E., Moretti, C., Bernardi, A. D., Alberti, A., Bergamasco, L., Trevi, G. P., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.026 · Cited by 24
Pleiotropic Effects of Calcium Channel Blockers
Mason, R. P. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0269-4 · Cited by 22
Self-citationStatin Potentiates Human Platelet eNOS Activity without Enhancing eNOS mRNA and Protein Levels
Yemişçi, M., Ay, H., Kocaefe, Ç., Qui, J., Topalkara, K., Özgüç, M., Kirazlı, Ş., Ozcebe, O. I., Moskowitz, M. A., & Dalkara, T. (2008) · Cerebrovascular Diseases · doi:10.1159/000145327 · Cited by 22
Perioperative use of statins in noncardiac surgery
Chan, Y. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.75 · Cited by 21
Boushra, N. N., & Muntazar, M. (2006) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022882 · Cited by 21
Formation and Cellular Impact of Cholesterol Crystals in Health and Disease
Baumer, Y., McCurdy, S., & Boisvert, W. A. (2021) · Advanced Biology · doi:10.1002/adbi.202100638 · Cited by 24
Banfi, C., Brioschi, M., Lento, S., Pirillo, A., Galli, S., Cosentino, S., Tremoli, E., & Mussoni, L. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04366.x · Cited by 19
Metadata
- Authors
- Mason, R. P., Walter, M. F., & Jacob, R. F.
- Affiliations
- From the Cardiovascular Division, Department of Medicine (R.P.M.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and the Cardiovascular Research Group (R.P.M., M.F.W., R.F.J.), Elucida Research LLC, Beverly, Mass.
- Brigham and Women's Hospital (US)
- Venue
- Circulation
- Published
- 2004-06
- Volume
- 109
- Issue
- 21_suppl_1
- Pages
- II34-41
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2148580947
- Cited by
- 175
- References
- 82
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2022: 1 · 2021: 8 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 6
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Pfizer
- National Heart, Lung, and Blood Institute
- National Eye Institute
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- statins, endothelial function, nitric oxide bioavailability, endothelial nitric oxide synthase, lipid rafts, cholesterol biosynthesis, terpenoids, cholesterol crystals, oxidative stress, reactive oxygen species, endothelial cell apoptosis, plaque stabilization
- MeSH terms
- Animals, Arteriosclerosis, Cholesterol, Crystallization, Endothelium, Vascular, Humans, Nitric Oxide, Oxidative Stress, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Membrane Microdomains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review